Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.
ESMO Open
; 6(1): 100044, 2021 02.
Article
in En
| MEDLINE
| ID: mdl-33516148
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplasms, Second Primary
/
Immune Checkpoint Inhibitors
Type of study:
Guideline
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
ESMO Open
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: